U.S. market Closed. Opens in 17 hours

ITOS | iTeos Therapeutics, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for ITOS we got that it has average fundamentals where Valuation is considered to be fairly valued, Profitability is unacceptably poor, Growth is good and Health is very strong.

Valuation (60%)

Company Industry
P/E Ratio (TTM) -6.13 -15.40
PEG Ratio (TTM) 0.03 -1.28
P/S Ratio (TTM) 25.74 47.91
P/B Ratio (TTM) 1.00 21.47
P/FCF Ratio (TTM) -5.19 5.35
Price to 5YR AVG Earnings Ratio 21.19 -0.30
Price to 5YR AVG FCF Ratio 12.51 -7.28

Profitability (25%)

Company Industry
ROA (TTM) -14.38% -2.96%
ROE (TTM) -18.19% 23.42%
Net Profit Margin (TTM) -456.33% -894.56%
ROIC 5YR AVG 35.73% 16.62%

Growth (67%)

4QTR AVG 3YR AVG 5YR AVG
EPS 17.28% 220.89% 78.29%
Revenue -25.00% N/A -23.53%
Net Income 16.88% 190.10% 59.76%
Cash Flow -23.85% 702.75% 398.65%

Health (72%)

Company Industry
Current Ratio (TTM) 18.08 5.73
Quick Ratio (TTM) 18.08 5.45
D/E Ratio (TTM) 0.01 -14.53
Interest Coverage (TTM) -17.70 3.88
Piotroski F-Score 1 5
Altman Z-Score 4.86 13.58
LTL to 5YR AVG FCF 0.10 0.21
Shares Outstanding Growth 5YR AVG 73.68% 117.96%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙